Bacterial Contamination and Antimicrobial Resistance of the Surrounding Environment Influencing Health
![]() |
Lee, Do Kyung
(College of Phamacy)
Park, Jae Eun (College of Phamacy) Kim, Kyung Tae (Department of Chemistry, Sahmyook University) Jang, Dai Ho (School of Life Sciences and Biotechnology, Korea University) Song, Young Cheon (College of Phamacy) Ha, Nam Joo (College of Phamacy) |
1 | Suarez, C., Pena, C., Tubau, F., Gavalda, L., Manzur, A., Dominguez, M.A., Pujol, M., Gudiol, F., and Ariza, J. 2009. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.J. Infect. 58, 285-290. DOI ScienceOn |
2 | Tasina, E., Haidich, A.B., Kokkali, S., and Arvanitidou, M. 2011. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. Lancet Infect. Dis. 11, 834-844. DOI ScienceOn |
3 | van Duin, D., Kaye K.S., Neuner, E.A., and Bonomo, R.A. 2013. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn. Microbiol. Infect. Dis. 75, 115-120. DOI ScienceOn |
4 | Wellington, E.M., Boxall, A.B., Cross, P., Feil, E.J., Gaze, W.H., Hawkey, P.M., Johnson-Rollings, A.S., Jones, D.L., Lee, N.M., Otten, W., and et al. 2013. The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect. Dis. 13, 155-165. DOI ScienceOn |
5 | Yoo, Y.A., Kim, M.S., Kim, K.S., Park, S.H., and Jung, S.K. 2010. Antimicrobial resistance and implicated genes of E. coli isolated from commercial and cooked foods in Seoul. J. Fd. Hyg. Safety 25, 220-225. |
6 | Chong, Y. and Lee, K. 2000. Present situation of antimicrobial resistance in Korea. J. Infect. Chemother. 6, 189-195. DOI ScienceOn |
7 | Clinical and Laboratory Standards Institute (CLSI). 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard, 9th ed. CLSI document M07-A79, CLSI, Wayne, PA, USA. |
8 | Dixon, B. 2000. Antibiotics as growth promotors: risks and alternatives. ASM News 66, 264-265. |
9 | Garau, J. 2008. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin. Microbiol. Infect. 14, 198-202. DOI ScienceOn |
10 | Price, J., Ekleberry, A., and Grover, A. 1999. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit. Care Med. 27, 2118-2124. DOI ScienceOn |
11 | Raji, M.A., Jamal, W., Ojemhen, O., and Rotimi, V.O. 2013. Point-surveillance of antibiotic resistance in Enterobacteriaceae isolates from patients in a Lagos Teaching Hospital, Nigeria. J. Infect. Public Health 6, 431-437. DOI ScienceOn |
12 | Rodriguez-Bano, J. and Pascual, A. 2008. Clinical significance of extended-spectrum beta-lactamases. Expert. Rev. Anti. Infect. Ther. 6, 671-683. DOI ScienceOn |
13 | Song, J.H. 2009. Current status and futures strategies of antimicrobial resistance in Korea. Kor. J. Med. 77, 143-151. |
14 | Spellberg, B., Blaser, M., Guidos, R.J., Boucher, H.W., Bradley, J.S., Eisenstein, B.I., Gerding, D., Lynfield, R., Reller, L.B., Rex, J., and et al. 2011. Combating antimicrobial resistance: policy recommendations to save lives. Clin. Infect. Dis. 52, S397-S428. DOI ScienceOn |
15 | Heinemann, J.A., Ankenbauer, R.G., and Amabile-Cuevasc, C.F. 2000. Do antibiotics maintain antibiotic resistance? Drug Discov. Today 5, 195-204. DOI ScienceOn |
16 | Kang, C.I. 2011. Therapeutic strategy for the management of multidrug-resistant Gram-negative bacterial infections. J. Kor. Med. Assoc. 54, 325-331. DOI ScienceOn |
17 | Lee, H.J., Yoon, H.B., Han, S.S., Cha, R., Oh, K.H., Joo, K.W., Park, S.W., Lim, C.S., and Oh, Y.K. 2008. Causative organisms and antibiotics sensitivity in community acquired acute oyelonephritis. Kor. J. Nephrol. 27, 688-695. |
18 | Kang, C.I. 2013. What's new in the management of bacterial infections in the era of multidrug-resistant bacteria? J. Kor. Soc. Transplant. 27, 81-86. DOI |
19 | Kang, C.I. and Song, J.H. 2013. Antimicrobial resistance in Asia: current epidemiology and clinical implications. Infect. Chemother. 45, 22-31. DOI ScienceOn |
20 | Kim, E.S., Song, J.S., Lee, H.J., Choe, P.G., Park, K.H., Cho, J.H., Park, W.B., Kim, S.H., Bang, J.H., Kim, D.M., and et al. 2007. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J. Antimicrob. Chemother. 60, 1108-1114. DOI ScienceOn |
21 | Martinez, J.L. 2009. Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ. Pollut. 157, 2893-2902. DOI ScienceOn |
22 | McGowan, Jr. J.E. 2001. Economic impact of antimicrobial resistance. Emerg. Infect. Dis. 7, 286-292. DOI ScienceOn |
23 | Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., and Leibovici, L. 2010. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob. Agents Chemother. 54, 4851-4863. DOI ScienceOn |
24 | Lee, K., Lim, C.H., Cho, J.H., Lee, W.G., Uh, Y., Kim, H.J., Yong, D., and Chong, Y. 2006. High prevalence of ceftazidime-resistant Klebsiella pneumonia and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. Yonsei Med. J. 47, 634-645. DOI ScienceOn |
25 | Fridkin, S.K., Hageman, J.C., Morrison, M., Sanza, L.T., Como-Sabetti, K., Jernigan, J.A., Hariman, K., Harrison, L.H., Lynfield, R., Farley, M.M. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352, 1436-1444. DOI ScienceOn |
![]() |